News - Page 192 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Psyched Wellness Initiates Study on AME-1 Extract for Gut Health

Psyched Wellness Initiates Study on AME-1 Extract for Gut Health

Post published:March 30, 2021
Post category:Press Release

Read more about the article MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform

MindMed Announces 2020 Year-End Financial Results; Current Cash Balance of $161 million USD ($203 million CAD) to Support Drug Development Pipeline and Creation of Psychedelic Medicine Tech Platform

Post published:March 30, 2021
Post category:Press Release

Read more about the article AIkido Pharma Sponsors Psychedelic Compound Research to Treat PTSD

AIkido Pharma Sponsors Psychedelic Compound Research to Treat PTSD

Post published:March 29, 2021
Post category:Press Release

Read more about the article Nova Mentis Announces Promising Research Results

Nova Mentis Announces Promising Research Results

Post published:March 29, 2021
Post category:Press Release

Read more about the article MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board

MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board

Post published:March 29, 2021
Post category:Press Release

Read more about the article Horizons ETFs Completes Rebalance of World’s First Psychedelics ETF

Horizons ETFs Completes Rebalance of World’s First Psychedelics ETF

Post published:March 27, 2021
Post category:Press Release

Read more about the article Champignon Brands Announces Filing of Listing Statement

Champignon Brands Announces Filing of Listing Statement

Post published:March 26, 2021
Post category:Press Release

Read more about the article Psychedelic Bulletin: UW-Madison Launches Psychedelic Master’s Program; COMPASS Granted 2 Patents

Psychedelic Bulletin: UW-Madison Launches Psychedelic Master’s Program; COMPASS Granted 2 Patents

Post published:March 26, 2021
Post category:Psychedelic Bulletin

Read more about the article Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness

Havn Life Sciences Signs LOI to Research and Develop Medical Psilocybin with Jamaican Company Hypha Wellness

Post published:March 25, 2021
Post category:Press Release

Read more about the article Psygen Industries Ltd. and Larose Ventures Ltd. Announce Reverse Takeover Transaction of 1290442 B.C. Ltd. by Psygen Industries Ltd. and Brokered Financing Led by Eight Capital and Canaccord

Psygen Industries Ltd. and Larose Ventures Ltd. Announce Reverse Takeover Transaction of 1290442 B.C. Ltd. by Psygen Industries Ltd. and Brokered Financing Led by Eight Capital and Canaccord

Post published:March 24, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.